RINVOQ Complete App | See abbv.ie/RinvoqPI

Описание: Visit https://abbv.ie/RinvoqPI to see Full Prescribing Info & Medication Guide. Watch to learn more about the Uses and Important Safety Information for RINVOQ® (upadacitinib).

Discover how the RINVOQ Complete App has something for everyone taking RINVOQ, all in one place. See Uses and Important Safety Information near the end of this video.

Go to https://abbv.ie/RinvoqComplete to see all the App can offer.

USES
RINVOQ is a prescription medicine used to treat:
• Adults with moderate to severe rheumatoid arthritis (RA) when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not be tolerated.
• Adults with active psoriatic arthritis (PsA) when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.
• Adults with active ankylosing spondylitis (AS) when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.
• Adults with active non-radiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation when a TNF blocker medicine has been used, and did not work well or could not be tolerated.
• Adults with giant cell arteritis (GCA).
• Adults with moderate to severe ulcerative colitis (UC) when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.
• Adults with moderate to severe Crohn’s disease (CD) when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.
It is not known if RINVOQ is safe and effective in children with ankylosing spondylitis, non-radiographic axial spondyloarthritis, ulcerative colitis, Crohn’s disease, and children under 2 years of age with polyarticular juvenile idiopathic arthritis (pJIA) or psoriatic arthritis.
• Adults and children 12 years of age and older with moderate to severe eczema (atopic dermatitis [AD]) that did not respond to previous treatment and their eczema is not well controlled with other pills or injections, including biologic medicines, or the use of other pills or injections is not recommended.
It is not known if RINVOQ is safe and effective in children under 12 years of age with atopic dermatitis.

SAFETY CONSIDERATIONS
RINVOQ may cause serious side effects, including:
• Serious infections. RINVOQ can lower ability to fight infections. Serious infections, some fatal, occurred, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses.
• Increased risk of death in people age 50+ with at least 1 heart disease risk factor.
• Cancer and immune system problems. Increased risk of some cancers, including lymphoma and skin. Current or past smokers have higher risk for lymphoma and lung cancer.
• Increased risk of major cardiovascular events such as heart attack, stroke, or death in people 50+ with at least 1 heart disease risk factor, especially in current or past smokers.
• Blood clots, some fatal, in veins of the legs or lungs and arteries. This occurred more often in people 50+ with at least 1 heart disease risk factor.
• Serious allergic reactions. Do not take if allergic to RINVOQ or its ingredients.
• Tears in the stomach or intestines; changes in certain laboratory test results.

Please see additional Important Safety Information here: https://abbv.ie/RinvoqISI

Learn more at: https://www.RINVOQ.com.

0:00 – 0:10 Please See Prescribing Information and Important Safety Information
0:11 – 0:25 App Features
0:26 – 0:40 Medication Reminders
0:41 – 1:00 Symptom & Goal Tracking
1:01 – 1:18 Ways to Save
1:19 – 1:31 Download the App
1:32 – 13:50 Important Safety Information